Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova,Mikkel Z Oestergaard,Marek Trněný,Wolfgang Hiddemann,Robert Marcus,Laurie H Sehn,Umberto Vitolo,Alexandra Bazeos,Valentin Goede,Harald Zeuner,Andrea Knapp,Denis Sahin,Nathalie Danesi,Christopher Bolen,Susan Robson,Jeffrey M Venstrom,Tina Nielsen,Günter Fingerle-Rowson

doi:10.1182/blood.v130.suppl_1.727.727

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova, Mikkel Z Oestergaard + Show 16 more

Open Access

https://doi.org/10.1182/blood.v130.suppl_1.727.727

Copy DOI

Journal: Blood	Publication Date: Dec 7, 2017
Citations: 2

Affiliation: Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Cologne, Roche (Switzerland), General University Hospital in Prague, Imperial College London, King's College Hospital, Ludwig-Maximilians-Universität München, BC Cancer Agency, University of British Columbia, Charles University

#Low Natural Killer Cell Count #Diffuse Large B-Cell Lymphoma Pts + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Full Text